Inventor · disambiguated record
Patrice Cani
Also filed as: CANI PATRICE · CANI PATRICE D · CANI PATRICE DANIEL
6 granted patents·19 pending applications·9 citations·filing 2009–2025
74Inventor score
Files withUNIV CATHOLIQUE LOUVAIN18THE AKKERMANSIA COMPANY2UNIV WAGENINGEN2A MANSIA BIOTECH1BIOCODEX1
Top patents by PatentIndex Score
25 records- 0184US10736924B2Use of pasteurized Akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2016·Granted Aug 11, 2020·2 cites·14 claims
- 0280US2025288622A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2025·Application pending·0 cites
- 0380US2025288621A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2025·Application pending·0 cites
- 0474US10738089B2Use of a polypeptide for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic statusUNIV WAGENINGEN·Filed 2016·Granted Aug 11, 2020·1 cites·26 claims
- 0573US8465788B2Arabinoxylans for modulating the barrier function of the intestinal surfaceEKHART PETER FRANK·Filed 2009·Granted Jun 18, 2013·6 cites·9 claims
- 0673US2020237832A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2019·Application pending·0 cites
- 0773US2020237833A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2019·Application pending·0 cites
- 0873US2021393704A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2021·Application pending·0 cites
- 0972US2021322489A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2021·Application pending·0 cites
- 1071US12370225B2Dysosmobacter, a novel bacterial genus of the gastrointestinal microbiota and uses thereofUNIV CATHOLIQUE LOUVAIN·Filed 2023·Granted Jul 29, 2025·0 cites·9 claims
- 1166US2020155616A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2019·Application pending·0 cites
- 1266US2020121737A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2019·Application pending·0 cites
- 1364US2019282630A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2019·Application pending·0 cites
- 1461US11466057B2Use of a polypeptide for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic statusUNIV WAGENINGEN·Filed 2020·Granted Oct 11, 2022·0 cites·7 claims
- 1560US11690879B2Dysosmobacter, a novel bacterial genus of the gastrointestinal microbiota and uses thereofUNIV CATHOLIQUE LOUVAIN·Filed 2019·Granted Jul 4, 2023·0 cites·1 claims
- 1660US2025057922A1Lipid nanocapsules charged with incretin mimeticsUNIV CATHOLIQUE LOUVAIN·Filed 2024·Application pending·0 cites
- 1759US2015306152A1Use of akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2013·Application pending·0 cites
- 1853US2024424031A1Composition comprising pasteurized akkermansia for the treatment or prevention of ibs-related anxietyTHE AKKERMANSIA COMPANY·Filed 2022·Application pending·0 cites
- 1953US2024350560A1Composition comprising pasteurized akkermansia muciniphila for the treatment or prevention of gut contractility disorders, in particular duodenal contraction amplitude disorderTHE AKKERMANSIA COMPANY·Filed 2022·Application pending·0 cites
- 2053US2025152637A1Akkermansia for preventing and/or treating reward dysregulation disordersUNIV CATHOLIQUE LOUVAIN·Filed 2023·Application pending·0 cites
- 2152US2023405076A1Composition comprising akkermansia muciniphila and green tea extractA MANSIA BIOTECH·Filed 2021·Application pending·0 cites
- 2250US2021015876A1Use of pasteurized akkermansia for treating metabolic disordersUNIV CATHOLIQUE LOUVAIN·Filed 2020·Application pending·0 cites
- 2349US2024415895A1Prevention and/or treatment of reward dysregulation disordersUNIV CATHOLIQUE LOUVAIN·Filed 2022·Application pending·0 cites
- 2443US2022347111A1Lipid nanocapsules charged with incretin mimeticsUNIV CATHOLIQUE LOUVAIN·Filed 2020·Application pending·0 cites
- 2539US2016287649A1Pharmaceutical composition for reducing body fatBIOCODEX·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrice Cani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →